Appendix 4E

• Sales revenue up 4% to $2,355.8 million
• EBIT up 9% to $517.8 million
• Net profit up 9% to $388.9 million
• Dividend increased 5% to $4.30 per share

Cochlear Limited, a leading global provider of implantable hearing solutions, has announced its preliminary financial results for the 2025 financial year. The company reported a 4% increase in sales revenue to $2,355.8 million, and a 5% increase in total revenue to $2,343.1 million. Earnings before interest and taxes (EBIT) grew by 9% to $517.8 million, while net profit for the period attributable to shareholders increased by 9% to $388.9 million. Underlying net profit, excluding one-off and non-recurring items, rose by 1% to $391.6 million. Basic earnings per share increased by 9% to 594.3 cents, while underlying basic earnings per share grew by 1% to 598.4 cents. The company also announced a 5% increase in the dividend, with a final dividend of $2.15 per share and an interim dividend of $2.15 per share, totaling $4.30 per share for the year. Net tangible assets per share at 30 June 2025 increased by 4% to 2,216.5 cents.